JULIE LETSEN: Open Payments
NPI 1881956282 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 11 payments from 8 companies in 2025. Trend: 2023 $951 · 2024 $1,161 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $61 |
| Journey Medical Corporation | 1 | $47 |
| GENZYME CORPORATION | 1 | $38 |
| UCB, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Organon LLC | 2 | $27 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, ILUMYA, Bimzelx, COSENTYX, Odomzo, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
